Themes | Prioritised by |
For asthma and COPD | |
Development and mechanisms | |
a. Genetic aetiological factors of asthma and COPD | E/P |
b. The mechanism of increase or decrease of symptoms of asthma and COPD | E/P |
c. The processes of asthma and COPD during life and their mechanisms | E |
i. Comorbidity/multimorbidity | P |
ii. Fatigue | P |
d. Factors (environmental and psychosocial) and lifestyles affecting the development asthma and COPD | E/P |
i. Air pollution, climate | E/P |
ii. Fear, depression, physical stress | P |
Care and treatment | |
a. The earliest stages of asthma and COPD and methods to ascertain these stages | E/P |
b. Possibilities to improve the treatment of asthma and COPD based on individual disease characteristics | P |
i. Compliance to treatment | E |
ii. Self-management | P |
Prevention | |
a. Interventions to prevent the development or progression of asthma and COPD | E/P |
i. Physical activity/physical therapy | E/P |
ii. Human smoking behaviour | E |
iii. Intervention to affect starting or stopping smoking | E |
For rare lung diseases | |
Development and mechanisms | |
a. Aetiological factors | E/P |
i. Genetic factors | E/P |
b. The process of chronic lung disease during life and their mechanisms | E/P |
i. Prognosis | P |
ii. Fatigue | P |
iii Airway infection in cystic fibrosis | E/P |
iv Biomarkers for prognoses and progression | E/P |
c. Factors (environmental and psychosocial) and lifestyles affecting the development of chronic lung diseases | E/P |
Care and treatment | |
a. The earliest stages of lung disease and methods to ascertain these stages | P |
b. Possibilities to improve the treatment of lung disease | E/P |
i. Compliance to treatment | E |
ii. Target finding for therapeutic interventions | E/P |
iii. Airway infections in cystic fibrosis | E/P |
iv. Physical activity/physical therapy | E/P |
Prevention | |
a. Prevention of development or progression of chronic lung diseases | E/P |
E: experts; P: patients.